| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 03/12/2008 | EP1897876A2 Compounds useful for the treatment of obesity, type II diabetes and CNS disorders |
| 03/12/2008 | EP1896415A1 Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/12/2008 | EP1896414A2 3-fluoro-piperidine t-type calcium channel antagonists |
| 03/12/2008 | EP1896405A2 Organic compounds |
| 03/12/2008 | EP1896036A1 Anti-inflammatory agents |
| 03/12/2008 | EP1896012A2 Anti-inflammatory agents |
| 03/12/2008 | EP1307194B1 Fentanyl composition for nasal administration |
| 03/12/2008 | CN101142186A Solid lercanidipine free base |
| 03/12/2008 | CN101141959A 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1 (Glyt-1) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 03/12/2008 | CN101139341A Indazolamides with analgesic activity |
| 03/12/2008 | CN101139340A N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 03/12/2008 | CN101139304A Conjugated dienamides and uses thereof |
| 03/12/2008 | CN100374421C 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 03/11/2008 | US7342116 Process for producing heterocyclic aldehyde |
| 03/11/2008 | US7342114 4-O esters such as thymin-1-yl alkyl ester; cancer; type II DNA topoisomerase inhibition, enzyme mediated production of lethal DNA strand breaks |
| 03/11/2008 | US7342027 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof |
| 03/11/2008 | US7341715 Method and agents on the basis of 2-mercaptopropionic acid amides for durable hair forming and a method for producing same |
| 03/11/2008 | CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders |
| 03/11/2008 | CA2310664C Substituted 2-aminoacetamides and the use thereof |
| 03/11/2008 | CA2192764C Integrin receptor antagonists |
| 03/06/2008 | WO2008025777A1 Novel piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 03/06/2008 | WO2008025240A1 Composition comprising amino heterocyclic compound for hair dyeing and dyeing method |
| 03/06/2008 | US20080058522 Process For The Preparation Of Enantiomerically Enriched Beta Amino Acid Derivatives |
| 03/06/2008 | US20080058515 indazolylacrylamide derivatives are useful in the treatment of diseases associated with inappropriate SGK-1 activity |
| 03/06/2008 | US20080058390 1-(6-substituted-pyridin-3-yl)cycloalkyl sulfoximines; controlling invertebrates, particularly aphids and other sucking insects; resistance to the old insecticides as DDT, carbamates, and organophosphates |
| 03/06/2008 | US20080058383 Such as 2-methyl-2-(4-nitro-3-trifluoromethyl-phenylamino)-propan-1-ol; prostate cancer; cardiovascular disorders; psychological disorders |
| 03/06/2008 | US20080058376 Useful in treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels; treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels; neuropathic pain |
| 03/06/2008 | US20080058374 Biphenyl-2-ylcarbamic acid 1-[2-({3-[2-(4-hydroxybenzylamino)ethylcarbamoyl]benzoyl}methylamino)ethyl]piperidin-4-yl ester; drug delivery; pulmonary disorders |
| 03/06/2008 | US20080058361 Tetrahydrobenzfluorene derivatives |
| 03/06/2008 | US20080058327 4-piperazinyl-5H-6,7-dihydrocyclopenta(d)pyrimidines; Hyperproliferative diseases such as cancer |
| 03/06/2008 | US20080058320 Organic Compounds |
| 03/06/2008 | US20080058315 Integrase inhibitors |
| 03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/06/2008 | US20080058311 Antagonizing N-type calcium channels; use as analgesic, neurodegenerative diseases, brain injury, bronchial asthma, unstable angina and irritable colitis, drug withdrawal symptoms; t-butyl 2-[4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-piperidinyl]-2-oxoethylcarbamate for example |
| 03/06/2008 | US20080057074 Nitrogenous Heterocylic Derivative and Medicine Containing the Same as an Active Ingredient |
| 03/05/2008 | EP1893603A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists |
| 03/05/2008 | EP1893578A2 Novel piperidine carboxylic acid amide derivatives |
| 03/05/2008 | EP1893577A1 Biphenyl compounds useful as muscarinic receptor antagonists |
| 03/05/2008 | EP1893573A1 Inhibitors of hcv replication |
| 03/05/2008 | EP1893569A1 Sulfonamide compounds and uses thereof |
| 03/05/2008 | EP1893201A1 Novel compounds of the family of iminosugars, uses thereof for treating lysosomal diseases, and method for preparing same |
| 03/05/2008 | EP1893200A2 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 03/05/2008 | CN101137646A Synthesis of ccr5 antagonists |
| 03/05/2008 | CN101137633A Process for the preparation of 1-aminopiperidine derivatives |
| 03/05/2008 | CN101137436A Base stable ionic liquids |
| 03/05/2008 | CN101134741A Catalyst for selective oxidation of protection monosaccharide primary hydroxy group |
| 03/05/2008 | CN100372855C 7-imino derivatives of camptothecin having antitumor activity |
| 03/05/2008 | CN100372840C Intermediate for the preparation of epimino |
| 03/05/2008 | CN100372838C Piperidine-benzenesulfonamide derivatives |
| 03/05/2008 | CN100372837C Substituted piperidines as novel MDM2-p53 inhibitors |
| 03/04/2008 | US7338976 Administering heterocyclic esters and amides: 3-phenyl-1-propyl(2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-(4-thiazolidine)carboxylate; 3-phenyl-1-propyl (2S)-1-(3,3-dimethyl-1,2-dioxopentyl)-2-pyrrolidinecarboxylate; immunosuppressants; affinity for an FK binding protein-type immunophilin |
| 03/04/2008 | US7338965 Enzyme inhibitors of beta-secretase which cleaves amyloid precursor protein present in Alzheimer's disease; Trisomy 21 (Down's Syndrome); Hereditary Cerebral Hemorrhage; cognition activators; Parkinson's disease |
| 03/04/2008 | US7338961 Sphingosine kinase inhibitors |
| 03/04/2008 | US7338960 {[2-Methyl-4-({[4'-(trifluoromethyl)-3-biphenylyl]methyl}thio)phenyl]oxy}acetic acid; adipogenic signalling cascade and lipid homeostasis; increase High Density Lipoproteins; hypotensive agent; Syndrome X, obesity, insulin resistance, cardiovascular disorder |
| 03/04/2008 | US7338952 N-[2-[4-[(4-chlorophenyl)ethynyl]-2-methylphenoxy]-1-methylethyl]-1,4-benzenedimethanamine; phosphorylation, polymorphonuclear leukocyte, macrophage, lipopolysaccharide, tumor necrosis factor- alpha, cytokine IFN- gamma, interleukin-2 mediated disorders ; arthritis, osteoarthritis, Alzheimer's disease |
| 03/04/2008 | US7338947 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/28/2008 | WO2008024963A1 Benzene, pyridine, and pyridazine derivatives |
| 02/28/2008 | WO2008023720A1 Urea compound or salt thereof |
| 02/28/2008 | WO2008023258A1 Piperidine derivatives |
| 02/28/2008 | WO2007016136A3 Organic nitric oxide enhancing salts of cyclooxygenase-2 selective inhibitors, compositons and methods of use |
| 02/28/2008 | US20080051579 Process for resolving chiral piperidine alcohol and process for synthesis of pyrazolo[1,5-a] pyrimidine derivatives using same |
| 02/28/2008 | US20080051434 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 02/28/2008 | US20080051404 Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| 02/28/2008 | US20080051401 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer |
| 02/28/2008 | US20080051393 Novel cannabinoids and methods of use |
| 02/28/2008 | US20080050296 using an aminoalcohol derived from 4-amino-2-butanol, which have a higher CO2 absorption capacity; global warming; e.g. 4-(diethylamino)-2-butanol or 4-(piperidino)-2-butanol |
| 02/28/2008 | CA2665804A1 Urea compound or salt thereof |
| 02/28/2008 | CA2661220A1 Multimediator transporter inhibitors for use in treatment of central nervous system disorders |
| 02/28/2008 | CA2661187A1 Piperidine derivatives |
| 02/27/2008 | EP1892241A1 Novel piperidine derivative |
| 02/27/2008 | EP1892238A1 1, 2-di(cyclic group)substituted benzene derivative |
| 02/27/2008 | EP1891954A2 Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder |
| 02/27/2008 | EP1891065A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders |
| 02/27/2008 | EP1891010A2 A process for the preparation of an injectable solution of (2s)-n-(2;6-dimethyl-phenyl)-1-propyl-2-piperidincarboxamide |
| 02/27/2008 | EP1891009A1 A novel process for the preparation of lercanidipine |
| 02/27/2008 | EP1749032B1 Alkoxyamines containing a radically polymerizable group |
| 02/27/2008 | EP1610786B9 4-(4-(heterocyclylalkoxy phenyl)-1-(heterocyclyl-carbonyl)piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer's |
| 02/27/2008 | EP1446115B1 Cyanoalkylamino derivatives as protease inhibitors |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | CN101133026A 1- sulfonyl-pi perdine- 3 -carboxyl i c acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus |
| 02/27/2008 | CN101133025A Organic compounds |
| 02/27/2008 | CN101133019A Derivatives of aminobutanoic acid inhibiting cpt |
| 02/27/2008 | CN101130514A Intermediate for the preparation of epimino |
| 02/27/2008 | CN100371326C New substituted pyridine or pyridine compound, their producing process and pharmaceutical composition containing them |
| 02/27/2008 | CN100370987C Tartrate salt of 5,8,14-triazatetracyclo [10,3,1,02,11.04,9]-hexzdeca-2(11),3,5,7,9-pentaene |
| 02/26/2008 | US7335788 S-(α, α′-disubstituted-α″-acetic acid) substituted dithiocarbonate derivatives for controlled radical polymerizations, process and polymers made therefrom |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | US7335681 Inhibit glucosyl ceramide (GlcCer) formation by inhibiting the enzyme GlcCer synthase; Gaucher's disease, Tay Sachs disease, Fabry's disease. Sandhoff disease or GM1 gangliosidosis |
| 02/26/2008 | US7335677 Inhibitors of dipeptidyl peptidase IV |
| 02/26/2008 | US7335673 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
| 02/26/2008 | US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 02/26/2008 | US7335380 Tablet, without excessive stickiness or tablet punch residue |
| 02/21/2008 | WO2008021509A1 Process for resolving chiral piperidine alcohol and process for synthesis of pyrazolo [1,5-a] pyrimidine derivatives using same |
| 02/21/2008 | WO2007121389A3 4,4-disubstituted piperidine derivatives as nk-i and serotonin transporter inhibitors |
| 02/21/2008 | WO2007101213A3 Novel 2-oxo-1,2,3,4-tetrahydropyrimidines, bicyclic pyrimidine diones and imidazolidine-2,4-diones useful as inducible nitric oxide synthase inhibitors |
| 02/21/2008 | US20080045546 Tetradydro-Naphthalene And Urea Derivatives |
| 02/21/2008 | US20080045544 Phenyl, Pyridine, Quinoline, Isoquinoline, Naphthyridine and Pyrazine Derivatives |
| 02/21/2008 | US20080045541 Dihydropyridinone Derivatives |
| 02/21/2008 | US20080045533 Novel cyclohexyl sulphones |
| 02/21/2008 | US20080045528 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting csf-1r signaling |